DrugPatentWatch Database Preview

Pharmalucence Company Profile

« Back to Dashboard

What is the competitive landscape for PHARMALUCENCE, and what generic and branded alternatives to PHARMALUCENCE drugs are available?

PHARMALUCENCE has fifteen approved drugs.

Summary for Pharmalucence

US Patents:	0
Tradenames:	15
Ingredients:	14
NDAs:	15

Drugs and US Patents for Pharmalucence

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pharmalucence	SELENOMETHIONINE SE 75	selenomethionine se-75	INJECTABLE;INJECTION	017322-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Pharmalucence	TECHNETIUM TC 99M SESTAMIBI	technetium tc-99m sestamibi kit	INJECTABLE;INJECTION	079157-001	Jul 10, 2009	AP	RX	No	No
Pharmalucence	IODOHIPPURATE SODIUM I 131	iodohippurate sodium i-131	INJECTABLE;INJECTION	017313-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Pharmalucence	HEPATOLITE	technetium tc-99m disofenin kit	INJECTABLE;INJECTION	018467-001	Mar 16, 1982		DISCN	No	No

Expired US Patents for Pharmalucence

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pharmalucence	IOBENGUANE SULFATE I 131	iobenguane sulfate i-131	INJECTABLE;INJECTION	020084-001	Mar 25, 1994	4,584,187

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Pharm Assoc
• Pharm Res Assoc
• Pharm Sourcing
• Pharm Spec